ES2255862A1 - Set of additives for skin peelings based on alpha hydroxy acids incorporate e.g. kojic acid in powders, dimethylamino ethanol, and palmitol pentapeptide in liquids - Google Patents
Set of additives for skin peelings based on alpha hydroxy acids incorporate e.g. kojic acid in powders, dimethylamino ethanol, and palmitol pentapeptide in liquidsInfo
- Publication number
- ES2255862A1 ES2255862A1 ES200403090A ES200403090A ES2255862A1 ES 2255862 A1 ES2255862 A1 ES 2255862A1 ES 200403090 A ES200403090 A ES 200403090A ES 200403090 A ES200403090 A ES 200403090A ES 2255862 A1 ES2255862 A1 ES 2255862A1
- Authority
- ES
- Spain
- Prior art keywords
- anyone
- additive
- function
- skin
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000654 additive Substances 0.000 title claims abstract description 98
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 229960002887 deanol Drugs 0.000 title claims abstract description 7
- 229940061720 alpha hydroxy acid Drugs 0.000 title claims abstract description 6
- 150000001280 alpha hydroxy acids Chemical class 0.000 title claims abstract description 6
- 206010040844 Skin exfoliation Diseases 0.000 title claims abstract 16
- 239000007788 liquid Substances 0.000 title claims description 11
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 title abstract description 6
- 229960004705 kojic acid Drugs 0.000 title abstract description 6
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 title abstract description 6
- 239000000843 powder Substances 0.000 title description 9
- 230000000996 additive effect Effects 0.000 claims abstract description 62
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 229920001436 collagen Polymers 0.000 claims abstract description 20
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 12
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 12
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 12
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims abstract description 12
- 240000003455 Piper longum Species 0.000 claims abstract description 11
- 230000003255 anti-acne Effects 0.000 claims abstract description 10
- 229950008882 polysorbate Drugs 0.000 claims abstract description 9
- 229920000136 polysorbate Polymers 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims abstract description 8
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 102000012422 Collagen Type I Human genes 0.000 claims abstract description 6
- 108010022452 Collagen Type I Proteins 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000021307 Triticum Nutrition 0.000 claims abstract description 6
- 229940067596 butylparaben Drugs 0.000 claims abstract description 6
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims abstract description 6
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 6
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims abstract description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 6
- 229960002216 methylparaben Drugs 0.000 claims abstract description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 6
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims abstract description 6
- 229960003415 propylparaben Drugs 0.000 claims abstract description 6
- 229960003471 retinol Drugs 0.000 claims abstract description 6
- 235000020944 retinol Nutrition 0.000 claims abstract description 6
- 239000011607 retinol Substances 0.000 claims abstract description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 5
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 5
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 241001593968 Vitis palmata Species 0.000 claims abstract description 4
- 229940038487 grape extract Drugs 0.000 claims abstract description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims abstract description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000014104 aloe vera supplement Nutrition 0.000 claims abstract description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940119217 chamomile extract Drugs 0.000 claims abstract description 3
- 235000020221 chamomile extract Nutrition 0.000 claims abstract description 3
- 235000011187 glycerol Nutrition 0.000 claims abstract description 3
- 229940094952 green tea extract Drugs 0.000 claims abstract description 3
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 3
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 3
- 239000011570 nicotinamide Substances 0.000 claims abstract description 3
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 3
- 239000008513 turmeric extract Substances 0.000 claims abstract description 3
- 230000003213 activating effect Effects 0.000 claims abstract 5
- 244000098338 Triticum aestivum Species 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims description 39
- APZYKUZPJCQGPP-UHFFFAOYSA-N Tetrahydropiperine Chemical compound C=1C=C2OCOC2=CC=1CCCCC(=O)N1CCCCC1 APZYKUZPJCQGPP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 11
- 235000019510 Long pepper Nutrition 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 6
- 230000004936 stimulating effect Effects 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 230000001815 facial effect Effects 0.000 claims description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 4
- 244000042664 Matricaria chamomilla Species 0.000 claims description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 3
- 241000167550 Centella Species 0.000 claims description 2
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 235000002532 grape seed extract Nutrition 0.000 claims description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 2
- 235000008696 isoflavones Nutrition 0.000 claims description 2
- 239000012190 activator Substances 0.000 claims 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract description 4
- 229960004889 salicylic acid Drugs 0.000 abstract description 4
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 abstract description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 abstract description 3
- 235000014655 lactic acid Nutrition 0.000 abstract description 3
- 239000004310 lactic acid Substances 0.000 abstract description 3
- 235000019136 lipoic acid Nutrition 0.000 abstract description 3
- 235000003687 soy isoflavones Nutrition 0.000 abstract description 3
- 229960002663 thioctic acid Drugs 0.000 abstract description 3
- 241000722363 Piper Species 0.000 abstract description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 6
- 206010040829 Skin discolouration Diseases 0.000 abstract 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 abstract 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 abstract 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 abstract 1
- 241001130943 Phyllanthus <Aves> Species 0.000 abstract 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 abstract 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 abstract 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 abstract 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 abstract 1
- 229940059958 centella asiatica extract Drugs 0.000 abstract 1
- 229960000448 lactic acid Drugs 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 229960004063 propylene glycol Drugs 0.000 abstract 1
- 229960004418 trolamine Drugs 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 16
- 239000000126 substance Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 6
- 241000209140 Triticum Species 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- 206010051246 Photodermatosis Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- -1 III and IV) Proteins 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 102000036444 extracellular matrix enzymes Human genes 0.000 description 1
- 108091007167 extracellular matrix enzymes Proteins 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229940097156 peroxyl Drugs 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Aditivos para peelings cutáneos.Additives for skin peels .
El objeto de la presente patente de invención es describir una serie de aditivos para los tratamientos dermatológicos conocidos como peelings. Estos aditivos se pueden aplicar tanto durante el tratamiento (aditivos en polvo), como en el post tratamiento (aditivos líquidos). Estos aditivos mejoran sustancialmente las virtudes de los peelings, en función de los efectos que se necesiten.The object of the present invention patent is to describe a series of additives for dermatological treatments known as scrubs . These additives can be applied both during treatment (powder additives), and after treatment (liquid additives). These additives substantially improve the virtues of the peels , depending on the effects that are needed.
Hasta el momento se han utilizado aditivos para toda clase de productos, con la idea de potenciar sus efectos o añadir características nuevas al producto original. Así, por ejemplo, los aditivos alimenticios retrasan la degradación (conservantes), los colorantes refuerzan el color, los saborizantes acentúan el sabor, etcétera.So far additives have been used to all kinds of products, with the idea of enhancing their effects or Add new features to the original product. So by For example, food additives delay degradation (preservatives), dyes reinforce color, flavorings Accentuate the taste, etc.
En general, y según la Real Academia Española, un aditivo, en su cuarta acepción es:In general, and according to the Royal Spanish Academy, a additive, in its fourth meaning is:
- "Sustancia que se agrega a otras para darles cualidades de que carecen o para mejorar las que poseen."" Substance that is added to others to give them qualities that they lack or to improve those they possess. "
Por otro lado, un peeling facial es un producto químico en forma de líquido o gel, formulado a base de alfa-hidroxiácidos (AHA's) cuyo efecto sobre la piel depende de la concentración y del pH.On the other hand, a facial peel is a chemical in the form of a liquid or gel, formulated based on alpha-hydroxy acids (AHA's) whose effect on the skin depends on the concentration and pH.
Aplicando la definición de aditivo al campo de los peelings cutáneos nos encontraríamos ante una sustancia de probada eficacia que se añade a determinados peelings cutáneos, en proporciones determinadas, para acentuar y/o mejorar tanto los efectos benéficos del peeling, corno el de las propias sustancias añadidas.Applying the definition of additive to the field of skin peels we would face a substance of proven efficacy that is added to certain skin peels, in determined proportions, to accentuate and / or improve both the beneficial effects of peeling , as well as the substances themselves added.
Establecidos los antecedentes de la presente patente de invención, solamente resta por añadir que el inventor, experto en este campo de la ciencia médica, desconoce de la existencia de algún aditivo específico para peelings cutáneos de iguales o similares características a los que se describen a continuación.Once the background of the present invention patent is established, it only remains to be added that the inventor, an expert in this field of medical science, is unaware of the existence of any specific additive for skin peels of the same or similar characteristics to those described below. .
Para completar el vacío existente en este campo de la técnica, se presentan los aditivos para peelings cutáneos, objeto de la presente patente de invención. Los aditivos para peelings cutáneos son sustancias de eficacia probada y que se añaden a determinados peelings cutáneas para acentuar sus efectos. Además estos se aportan en cantidad suficiente para conseguir una concentración relativamente alta en el peeling, sin modificar significativamente las características del mismo.In order to complete the vacuum existing in this field of the art, the additives for skin peels , object of the present invention patent, are presented. Additives for skin peels are substances of proven efficacy and are added to certain skin peels to accentuate their effects. In addition, these are provided in sufficient quantity to achieve a relatively high concentration in the peel , without significantly modifying its characteristics.
Los peelings consiguen eliminar la capa córnea de la piel y permiten la penetración de altas concentraciones del activo del peeling en la piel, mejorando los resultados. Asimismo, el peeling acentúa la penetración transepidérmica y permite la penetración de ingredientes inestables, como la vitamina C, a altas concentraciones.The peels manage to eliminate the corneal layer of the skin and allow the penetration of high concentrations of the peeling active in the skin, improving the results. Also, the peel accentuates transepidermal penetration and allows the penetration of unstable ingredients, such as vitamin C, at high concentrations.
En la presente patente de invención se presentan una serie de aditivos, cada uno de los cuales dispone de unas características propias. Estos aditivos se dividen en dos familias, los aditivos en polvo y los aditivos líquidos.In the present invention patent are presented a series of additives, each of which has some own characteristics. These additives are divided into two families, powder additives and liquid additives.
Los aditivos en polvo se han diseñado para ser mezclados en las proporciones recomendadas con el peeling en el momento de la aplicación. La mezcla de ambos productos se producirá como sigue:Powder additives have been designed to be mixed in the recommended proportions with peeling at the time of application. The mixing of both products will be produced as follows:
- --
- Se tomarán entre 1,5 y 2,5 gr. de aditivo y se colocarán en un recipiente.Be they will take between 1.5 and 2.5 gr. of additive and will be placed in a container.
- --
- Se tomarán aproximadamente 8,5 gr. de peeling y se colocarán en el mismo recipiente.Approximately 8.5 gr will be taken. of peeling and will be placed in the same container.
- --
- Se homogeneizará la mezcla con ayuda de una espátula y se aplicará sobre la piel.Be homogenize the mixture with the help of a spatula and apply on the skin.
Estos aditivos en polvo, a su vez, se dividen en cinco clases en función de su utilidad principal: despigmentante, despigmentante-k, antioxidante, luminoso y anti-acné.These powder additives, in turn, are divided into five classes based on their main utility: depigmenting, depigmenting-k, antioxidant, bright and anti-acne
El aditivo luminoso está basado en ácido ascórbico y tetrahidropiperina. Está especialmente indicado para combatir el fotoenvejecimiento, las pigmentaciones cutáneas o melasmas, estrías y cicatrices, así como acentuar la fotoprotección. El ácido ascórbico es un elemento bien conocido en aplicaciones dermatológicas, mientras que la tetrahidropiperina se prepara a partir de la piperina (principios activos de la pimienta) y mejora la penetración de los ingredientes activos acelerando su absorción.The luminous additive is acid based ascorbic and tetrahydropiperine. It is especially suitable for combat photoaging, skin pigmentation or melasmas, stretch marks and scars, as well as accentuate the photoprotection Ascorbic acid is a well known element in dermatological applications, while tetrahydropiperine is prepare from piperine (active ingredients of pepper) and improves the penetration of active ingredients by accelerating their absorption.
El aditivo antioxidante está basado en ácido ascórbico, ácido tioctico, extracto de uva, isoflavonas de soja y tetrahidropiperina. El ácido tióctico es un antioxidante que inhibe la tirosonasa y las proteasas degradantes de matriz, mientras que las isoflavonas de la soja contienen fitoestrógenos como la genisteína, y la gaidzena. La genisteína estimula la síntesis de colágeno y tiene una acción antioxidante bloqueando los radicales peroxilo, reduciendo la peroxidación lipídica. Asimismo, reduce el enrojecimiento, tiene acción anti-inflamatoria y reduce el efecto immunosupresor de la RUV (radiación ultravioleta).The antioxidant additive is acid based ascorbic, thioctic acid, grape extract, soy isoflavones and tetrahydropiperine. Thioctic acid is an antioxidant that inhibits tyrosonase and matrix degrading proteases, while soy isoflavones contain phytoestrogens such as Genistein, and Gaidzena. Genistein stimulates the synthesis of collagen and has an antioxidant action blocking radicals peroxyl, reducing lipid peroxidation. It also reduces the redness, has anti-inflammatory action and reduces the immunosuppressive effect of the RUV (radiation ultraviolet).
Por otro lado, la uva roja es rica en polifenoles y tiene una potente acción antioxidante, además disminuye la capacidad de la RUV de inducir cánceres de piel y enrojecimiento.On the other hand, the red grape is rich in polyphenols and has a powerful antioxidant action, also decreases the ability of the RUV to induce skin cancers and redness
El aditivo antioxidante está especialmente indicado para la reducción del daño solar, el fotoenvejecimiento, las pieles enrojecidas, los melasmas y el acné hormonal asociado con la menopausia.The antioxidant additive is especially indicated for the reduction of sun damage, photo aging, flushed skin, melasmas and associated hormonal acne With menopause
El aditivo despigmentante-k está basado, únicamente, en el ácido kójico, además de tetrahidropiperina, con los efectos anteriormente mencionados. Los efectos del ácido kójico son bien conocidos en el campo de la dermatología como potente despigmentador.The depigmenting additive-k is based solely on kojic acid, in addition to tetrahydropiperine, with the aforementioned effects. The Kojic acid effects are well known in the field of dermatology as a powerful depigmentor.
El aditivo despigmentante está basado principalmente en ácido kójico, pero añadiéndole Phyllantus emblica, tetrahidrocurcuminoides, te verde en polvo y tetrahidropiperina.The depigmenting additive is based mainly on kojic acid, but adding Phyllantus emblica , tetrahydrocurcuminoids, green tea powder and tetrahydropyperine.
La Phyllantus emblica es el polvo de la fruta del mismo nombre (Emblica officinalis) y es rica en vitamina C y polifenoles, además tiene actividad antioxidante y reduce la hiperpigmentación o pecas. Por otro lado, las tetrahidrocurcuminoides son compuestos polifenólicos derivados de los curcuminoides (que son extraidos de las raíces de la Curcuma longa), tienen una acción antioxidante mayor que la vitamina E además de una acción antiinflamatoria y despigmentante. El té verde se consume ampliamente en Asia y ofrece un apreciable instante de "tranquilidad" a las células por sus propiedades antiradicalares. Asimismo, contiene polifenoles que previenen el daño oxidativo debido a las agresiones externas como las radiaciones UV del sol, ayudando a la piel a preservar su juventud. Phyllantus emblica is the fruit powder of the same name ( Emblica officinalis ) and is rich in vitamin C and polyphenols, it also has antioxidant activity and reduces hyperpigmentation or freckles. On the other hand, tetrahydrocurcuminoids are polyphenolic compounds derived from curcuminoids (which are extracted from the roots of Curcuma longa ), have an antioxidant action greater than vitamin E in addition to an anti-inflammatory and depigmenting action. Green tea is widely consumed in Asia and offers an appreciable moment of "tranquility" to the cells for their anti-radical properties. It also contains polyphenols that prevent oxidative damage due to external aggressions such as UV radiation from the sun, helping the skin to preserve its youth.
Finalmente, el aditivo anti-acné está compuesto básicamente de niacimida, ácido salicílico, manzanilla, aloe vera y tetrahidropiperina.Finally, the anti-acne additive It is basically composed of niacimide, salicylic acid, chamomile, aloe vera and tetrahydropiperine.
La niacimida es esencialmente vitamina B3, bien conocida como muy útil en el tratamiento tópico del acné, además posee una potente acción antiinflamatoria que junto con la del ácido salicílico, no tiene riesgo de inducir resistencias bacterianas. El ácido salicílico es un \beta-hidroxiácido, de molécula más grande que los AHAS (\alpha-hidroxiácidos). Además es un lipofílico que penetra más lenta y profundamente en la piel permitiendo una exfoliación mayor dentro del poro, también es un agente queratolítico (que promueve la exfoliación de los corneocitos) acelerando el recambio celular. Asimismo, reduce las lesiones de acné, piel grasa, alteraciones texturales e hiperpigmentaciones post-inflamatorias.Niacimide is essentially vitamin B3, well known as very useful in the topical treatment of acne, in addition It has a powerful anti-inflammatory action that together with the Salicylic acid, has no risk of inducing resistance bacterial Salicylic acid is a β-hydroxy acid, larger molecule than AHAS (α-hydroxy acids). It is also a lipophilic that penetrates slower and deeper into the skin allowing a greater exfoliation inside the pore, it is also a keratolytic agent (which promotes the exfoliation of corneocytes) accelerating cell turnover. It also reduces acne lesions, oily skin, textural alterations and post-inflammatory hyperpigmentation.
Los aditivos líquidos son para uso posterior a la aplicación del peeling facial, aplicándose mediante un ligero masaje después de la realización del tratamiento.The liquid additives are for use after the application of facial peeling , applying a light massage after the treatment.
Los aditivos líquidos se dividen en dos clases: aditivos estimuladores del colágeno (I, II y III) y aditivo lifting.Liquid additives are divided into two classes: collagen stimulating additives (I, II and III) and lifting additive.
Los aditivos estimuladores del colágeno están basados en el palmitoil-pentapéptido, en el ascorbil-2-glucósido, la centella asiática, y el retinol.Collagen stimulating additives are based on palmitoyl-pentapeptide, in the ascorbil-2-glycoside, the scintillation Asian, and retinol.
El palmitoil-pentapéptido es un micro-colágeno que imita el proceso de regeneración natural de los tejidos (repara la matriz y la unión D-E) enviando señales a las células de la dermis para sintetizar proteínas (colágeno I, III y IV), fibronectina y GAGs (ácido hialurónico) que recomponen el tejido conectivo necesario para estructurar la piel. Contra el fotoenvejecimiento es tan eficaz como el retinol. Por otro lado, la centella asiática estimula el fibroblasto y la síntesis del colágeno I, con lo que tenernos un componente de características reafirmantes, regenerantes, reparadoras y suavizantes, además inhibe el proceso inflamatorio que podría provocar hipertrofia en cicatrices. Finalmente, el retinol es una vitamina liposoluble, con acción antioxidante, regenerante, normalizadora de la queratinización, que regula el proceso de renovación celular. Además aumenta el grosor de dermis y epidermis.Palmitoyl-pentapeptide is a micro-collagen that mimics the regeneration process natural tissue (repair matrix and joint D-E) sending signals to the dermis cells to synthesize proteins (collagen I, III and IV), fibronectin and GAGs (hyaluronic acid) that make up connective tissue necessary to structure the skin. Against photoaging is as effective as retinol. On the other hand, the Asian sparkle stimulates fibroblast and the synthesis of collagen I, thereby have a component of firming characteristics, regenerating, repairing and softening, also inhibits the process inflammatory that could cause hypertrophy in scars. Finally, retinol is a fat-soluble vitamin, with action antioxidant, regenerating, normalizing keratinization, which regulates the process of cell renewal. It also increases the thickness of dermis and epidermis.
El aditivo lifting está basado en el DMAE (dimetilamino etanol), el ácido láctico y las proteínas de trigo.The lifting additive is based on DMAE (dimethylamino ethanol), lactic acid and wheat proteins.
El DMAE es un componente que libera acetilcolina, que es un neurotransmisor requerido para la contracción muscular, es decir, lo que conseguimos con este compuesto es un mejor tono muscular en los músculos cutáneos. El ácido láctico se utiliza para disolver el DMAE en forma líquida.DMAE is a component that releases acetylcholine, which is a neurotransmitter required for muscle contraction, that is, what we get with this compound is a better tone muscle in the skin muscles. Lactic acid is used to dissolve the DMAE in liquid form.
Esta solución tiene un pH alto, luego hay que neutralizarlo. Las proteínas de trigo son agentes tensores, de alto peso molecular, obtenido de fracciones especiales de proteínas del trigo, purificadas y seleccionadas por sus propiedades viscoelásticas.This solution has a high pH, then you have to neutralize it Wheat proteins are high tensing agents molecular weight, obtained from special protein fractions of wheat, purified and selected for their properties viscoelastic
A modo de conclusión, podemos indicar que los aditivos para peelings, objeto de la presente patente de invención, tienen las siguientes ventajas:By way of conclusion, we can indicate that the additives for peels , object of the present invention patent, have the following advantages:
- 1.-one.-
- Es un procedimiento a la carta, es decir, se diseña para cada paciente y problema.Is an à la carte procedure, that is, is designed for each patient and problem
- 2.-2.-
- Permite el uso de diversos activos a concentraciones altas.It allows the use of various assets to high concentrations
- 3.-3.-
- El activo se incorpora inmediatamente al dispositivo de entrega, permitiendo el uso de activos inestables como la vitamina C.He asset is immediately incorporated into the delivery device, allowing the use of unstable assets such as vitamin C.
- 4.-4.-
- Se acentúan los resultados del peeling y del aditivo, rápidas mejorías clínicas.The results of the peeling and the additive are accentuated, rapid clinical improvements.
- 5.-5.-
- Supone un cambio muy favorable en la forma en que actualmente se realizan los peelings.It is a very favorable change in the way in which the peels are currently made.
Los aditivos para peelings cutáneos, objeto de la presente patente de invención, son una serie de aditivos con unas características y composiciones diferenciadas. Se dividen en dos grandes grupos, los aditivos en polvo y los aditivos líquidos.The additives for skin peels , object of the present invention patent, are a series of additives with different characteristics and compositions. They are divided into two large groups, powder additives and liquid additives.
Los aditivos en polvo se dividen, a su vez, en cinco tipos según su funcionalidad: despigmentante, despigmentante-k, antioxidante, luminoso y anti-acné.Powder additives are divided, in turn, into Five types according to their functionality: depigmenting, depigmenting-k, antioxidant, bright and anti-acne
La composición del aditivo despigmentante, en nomenclatura química internacional, se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the depigmenting additive, in International chemical nomenclature, is stated below. The maximum and minimum weights correspond to the percentages of maximum and minimum admissible ingredient to maintain results dermatologically acceptable, adjusting the rest of ingredients:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La composición del aditivo despigmentante-k, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the additive depigmenting-k, in chemical nomenclature International is listed below. The maximum and minimum weights correspond to the percentages of the maximum and minimum ingredient admissible to maintain results dermatologically acceptable, adjusting the rest of the ingredients:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La composición del aditivo antioxidante, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the antioxidant additive, in International chemical nomenclature is set forth below. The maximum and minimum weights correspond to the percentages of maximum and minimum admissible ingredient to maintain results dermatologically acceptable, adjusting the rest of ingredients:
\newpage\ newpage
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La composición del aditivo luminoso, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the luminous additive, in International chemical nomenclature is set forth below. The maximum and minimum weights correspond to the percentages of maximum and minimum admissible ingredient to maintain results dermatologically acceptable, adjusting the rest of ingredients:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
La composición del aditivo anti-acné, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the additive anti-acne, in international chemical nomenclature it set forth below. The maximum and minimum weights correspond to the percentages of the maximum and minimum admissible ingredient for maintain dermatologically acceptable results by adjusting the rest of the ingredients:
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los aditivos líquidos son para uso posterior a la aplicación del peeling facial, aplicándose mediante un ligero masaje después de la realización del tratamiento. Los aditivos líquidos se dividen en dos tipos, los aditivos estimuladores de colágeno (I, II y III) y el aditivo lifting.The liquid additives are for use after the application of facial peeling , applying a light massage after the treatment. Liquid additives are divided into two types, collagen stimulating additives (I, II and III) and lifting additive.
La composición del aditivo estimulador de colágeno I, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the stimulant additive of collagen I, in international chemical nomenclature is stated continuation. The maximum and minimum weights correspond to the maximum and minimum allowable ingredient percentages to maintain Dermatologically acceptable results, adjusting the rest of ingredients:
\newpage\ newpage
La composición del aditivo estimulador de colágeno II, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the stimulant additive of collagen II, in international chemical nomenclature is stated continuation. The maximum and minimum weights correspond to the maximum and minimum allowable ingredient percentages to maintain Dermatologically acceptable results, adjusting the rest of ingredients:
La composición del aditivo estimulador de colágeno III, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the stimulant additive of collagen III, in international chemical nomenclature is stated continuation. The maximum and minimum weights correspond to the maximum and minimum allowable ingredient percentages to maintain Dermatologically acceptable results, adjusting the rest of ingredients:
La composición del aditivo lifting, en nomenclatura química internacional se enuncia a continuación. Los pesos máximos y mínimos corresponden a los porcentajes del ingrediente máximo y mínimo admisible para mantener unos resultados dermatológicamente aceptables, ajustando el resto de ingredientes:The composition of the lifting additive, in international chemical nomenclature is set forth below. The maximum and minimum weights correspond to the percentages of the maximum and minimum admissible ingredient to maintain dermatologically acceptable results, adjusting the rest of the ingredients:
Una vez descrita suficientemente la naturaleza de la presente invención, así como una forma de llevarla a la práctica, solamente queda por añadir que dicha invención puede sufrir ciertas variaciones en su distribución porcentual entre ingredientes, siempre y cuando dichas alteraciones no varíen sustancialmente las características que se reivindican a continuación.Once the nature of the present invention, as well as a way of bringing it to the practice, it only remains to be added that said invention can suffer certain variations in its percentage distribution between ingredients, as long as these alterations do not vary substantially the characteristics that are claimed to continuation.
Claims (3)
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\newpage\ newpage
- \bullet?
- Se tomarán entre 1,5 y 2,5 gramos de aditivo y se colocan en un recipiente.They will take between 1.5 and 2.5 grams of additive and placed in a container.
- \bullet?
- Se tomarán aproximadamente 8,5 gramos de peeling y se colocan en el mismo recipiente que el aditivo.It will take approximately 8.5 grams of peeling and placed in the same container as the additive.
- \bullet?
- Se homogeneizará la mezcla con ayuda de una espátula y se aplica sobre la piel.The mixture will be homogenized with help of a spatula and is applied on the skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200403090A ES2255862B1 (en) | 2004-12-27 | 2004-12-27 | ADDITIVES FOR CUTANEOUS PEELINGS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200403090A ES2255862B1 (en) | 2004-12-27 | 2004-12-27 | ADDITIVES FOR CUTANEOUS PEELINGS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2255862A1 true ES2255862A1 (en) | 2006-07-01 |
ES2255862B1 ES2255862B1 (en) | 2007-07-16 |
Family
ID=36638444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200403090A Active ES2255862B1 (en) | 2004-12-27 | 2004-12-27 | ADDITIVES FOR CUTANEOUS PEELINGS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2255862B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013014427A1 (en) * | 2011-07-22 | 2013-01-31 | Nicholas Lowe | Compositions for treatment of skin disorders |
JP2014526561A (en) * | 2011-09-23 | 2014-10-06 | アラーガン、インコーポレイテッド | Composition for skin exfoliation and use thereof |
CN111012713A (en) * | 2019-12-31 | 2020-04-17 | 广州市科能化妆品科研有限公司 | Whitening composition and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2050074A1 (en) * | 1991-08-23 | 1994-05-01 | Fischer Pharma Ltd | Compositions containing flavonoids |
ES2152710T3 (en) * | 1996-12-28 | 2001-02-01 | Singh Verma Shyam Bir Dr | COSMETIC PREPARATIONS FOR TOPICAL APPLICATION CONTAINING EXTRACTS FROM PHYLLANTHUS EMBLICA AND CENTELLA ASIATICA AND / OR BACOPA MONNIERI. |
EP1479374A1 (en) * | 2003-05-22 | 2004-11-24 | L'oreal | Process for the cosmetic treatment of cutaneous erythema or skin redness |
-
2004
- 2004-12-27 ES ES200403090A patent/ES2255862B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2050074A1 (en) * | 1991-08-23 | 1994-05-01 | Fischer Pharma Ltd | Compositions containing flavonoids |
ES2152710T3 (en) * | 1996-12-28 | 2001-02-01 | Singh Verma Shyam Bir Dr | COSMETIC PREPARATIONS FOR TOPICAL APPLICATION CONTAINING EXTRACTS FROM PHYLLANTHUS EMBLICA AND CENTELLA ASIATICA AND / OR BACOPA MONNIERI. |
EP1479374A1 (en) * | 2003-05-22 | 2004-11-24 | L'oreal | Process for the cosmetic treatment of cutaneous erythema or skin redness |
Non-Patent Citations (2)
Title |
---|
THIOLY-BENSOUSSAN, D. "Depigmentary treatment up-to-date. Experience of melasma treatment" "Actualites des traitements depigmentants. Experience dans le traitement des melasmas". Nouvelles Dermatologiques, 2003. Vol. 22, n 3, paginas 217-219. * |
THIOLY-BENSOUSSAN, D. "Depigmentary treatment up-to-date. Experience of melasma treatment" "Actualités des traitements dépigmentants. Expérience dans le traitement des mélasmas". Nouvelles Dermatologiques, 2003. Vol. 22, nº 3, páginas 217-219. * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013014427A1 (en) * | 2011-07-22 | 2013-01-31 | Nicholas Lowe | Compositions for treatment of skin disorders |
JP2014526561A (en) * | 2011-09-23 | 2014-10-06 | アラーガン、インコーポレイテッド | Composition for skin exfoliation and use thereof |
CN111012713A (en) * | 2019-12-31 | 2020-04-17 | 广州市科能化妆品科研有限公司 | Whitening composition and preparation method and application thereof |
CN111012713B (en) * | 2019-12-31 | 2022-05-13 | 广州市科能化妆品科研有限公司 | Whitening composition and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
ES2255862B1 (en) | 2007-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090053290A1 (en) | Transdermal drug delivery compositions and topical compositions for application on the skin | |
CN102293733B (en) | Overall whitening and speckle removal skin care product | |
CN104856892A (en) | Cosmetic or skin care product preparation rich in growth factors and preparation method therefor | |
US8911774B2 (en) | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use | |
US20170304371A1 (en) | Skincare preparations | |
WO2011116216A2 (en) | Topical skin care composition | |
BRPI0504797B1 (en) | topical formulation, cosmetic treatment method for skin rejuvenation, cosmetic treatment method and use of a formulation | |
CN108618987A (en) | A kind of external preparation of skin nursing and preparation method thereof | |
CN104825347B (en) | A kind of medical bio whitening and spot-eliminating dressing and preparation method thereof | |
CN106580732A (en) | Emulsion and preparation method thereof | |
CN104288002A (en) | Preparation method of energy supplement compound for cosmetics | |
EP3558374A1 (en) | Biophotonic compositions comprising lichen extract and their use to treat skin disorders | |
US20160243021A1 (en) | Collagen-Boosting Compositions And Methods | |
CN109568159A (en) | Cosmetic composition and its preparation method and application is repaired in a kind of whitening | |
ES2255862B1 (en) | ADDITIVES FOR CUTANEOUS PEELINGS. | |
EP2695610B1 (en) | Food supplement for improving connective tissue health | |
AU2014304620A1 (en) | Composition for skin anti-ageing treatment | |
CN104323966A (en) | Golden hydrotherapy composition and using method thereof | |
CN108938511B (en) | Composition of natural plant extracts and application of composition in skin moisturizing and acne removing products | |
WO2015010372A1 (en) | Cream used for treatment of acne hyperpigmentation spot and for whitening | |
KR101697340B1 (en) | Cosmetic composition containing ginseng berry extracts and polygonum multiflorum extracts | |
RU2384322C2 (en) | Day gel cream for dry and normal skin | |
US10780142B2 (en) | Aloe-hyplex topical formulation and a method of preparation | |
JP2021500393A (en) | Cosmetic use of plant elephant extract (Phytelephas sp.) | |
CN107157846A (en) | A kind of anti-acne facial treatment mask |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20060701 Kind code of ref document: A1 |
|
FG2A | Definitive protection |
Ref document number: 2255862B1 Country of ref document: ES |